| Dittmar, Gita (Ethris 201708 Head Corp Development before Biogen Idex + Dance Biopharma) |
Business Development Manager / Strategy Manager |
Ethris GmbH |
Germany |
| Dittmar, Thorsten (Univ Oldenburg 201009 ICBM Head Max Planck Research Group Marine Geochemistry) |
Researcher (university / research institute) |
University of Oldenburg (Carl von Ossietzky University) |
Germany |
| Dittmer, Janke (Gilde Investment 201210 Partner at Gilde Healthcare Partners) |
Partner (venture partner) |
Gilde Investment (Group) |
Netherlands |
| Dittmer, Thomas (Zytomed Systems 200912 Managing Director) |
Managing Director |
ZytoVision (Group) |
Germany |
| Ditzinger, Günter (Basilea 201602– promoted CTO joined 2002 before Novartis Pharma + Hoechst Marion Roussel) |
Chief Technology/Technical Officer (CTO) |
Basilea (Group) |
Switzerland |
| Divan, Khalil (Thermo Fisher 201511 Senior Director Marketing Food + Beverage) |
Sales Manager / Marketing Manager |
Thermo Fisher (Group) |
United States (USA) |
| DiVincenzo, Jonathan (Jon) (PerkinElmer 201312– President Environmetal Health before Enzymatics + Merck Millipore) |
President/Director/Head Business Group/Unit/Division |
PerkinElmer (Group) |
United States (USA) |
| Dixit, Upendra (Endress+Hauser 201411– Managing Director of AJ Instruments India Pvt Ltd) |
Managing Director |
Endress+Hauser (Group) |
India |
| Dixon, Graham (Onxeo 2015– CSO before Sensorion + Addex + Galapagos + Entomed + F2G + AstraZeneca) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Onxeo (Group) |
France |
| Dobai, Zoltan (EveliQure Biotechnologies 201509 Managing Director) |
Managing Director |
EveliQure Biotechnologies GmbH |
Austria |
| Dobbs, Felix (Broken String Biosciences 202309 CEO) |
Chief Executive Officer (CEO) |
Broken String Biosciences Ltd. |
United Kingdom (GB) |
| Dobmeier, Eric (Chinook Therapeutics 202306 CEO) |
Chief Executive Officer (CEO) |
Novartis (Group) |
United States (USA) |
| Dobmeyer, Thomas (PharmaLex 202010 Managing Director) |
Managing Partner |
PharmaLex (Group) |
Germany |
| Dochez, Luc (Vico Therapeutics 202007 CEO + Co-Founder + Droia Genetic Disease Fund Managing Partner before Prosensa) |
Chief Business Officer (CBO) |
Vico Therapeutics B.V. |
Netherlands |
| Doebler, Maximilian (HMNC 202208– promoted to CBO before Head of BusDev + Licensing + Maschmeyer Group + KPMG) |
Chief Business Officer (CBO) |
HMNC (Holsboer / Maschmeyer) (Group) |
Germany |
| Doerfler, Douglas (Doug) (MaxCyte 201006 CEO) |
Chief Executive Officer (CEO) |
MaxCyte (Group) |
United States (USA) |
| Doheny, Noel Thomas (Epigenomics 201105– CEO Epigenomics Inc before OpGen CEO + Affymetrix + Qiagen + Biostar) |
Chief Executive Officer (CEO) |
Epigenomics (Group) |
United States (USA) |
| Doherty, Elizabeth (Novartis 201602– Board Director PROPOSED) |
Board member, non-executive |
Novartis (Group) |
Switzerland |
| Dohrmann, Cord (Evotec 201009– CSO before 10y at DeveloGen incl CSO + CEO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Evotec (Group) |
Germany |
| Dolan, Daniel (Nabriva 202103– CFO before Radius Health + Shire Pharmaceuticals) |
Chief Financial Officer (CFO) |
Nabriva (Group) |
Ireland, Republic of |
| Dolfe, Sofia (Index Ventures 202211 Partner) |
Partner (venture partner) |
Index Ventures |
Switzerland |
| Dollase, Manja |
n. a. |
Brandenburg (govt region) |
Germany |
| Dollinger, Manuela (Wacker 202206 Media Relations + Information) |
Public Relations Manager / Investor Relations Manager |
Wacker (Group) |
Germany |
| Domagk, Gerhard |
n. a. |
Bayer (Group) |
Germany |
| Dombrosky, John (Bayer 201910– CEO of Oerth Bio) |
Chief Executive Officer (CEO) |
Bayer (Group) |
|
| Domdey, Anke (invest4biotech 201410 Partner before + LEO Pharma + BioXell + Boehringer) |
Consultant (economic/technology) |
invest4biotech (i4b) |
Denmark |
| Domdey, Horst (BioM 1997–202212 Managing Director RETIRED 12/22) |
Cluster Manager |
Bavaria (govt region) |
Germany |
| Domin, André H. R. (Heidelberg (govt)– 201102 Managing Director of Technologiepark Heidelberg GmbH) |
Managing Director |
Heidelberg (govt city) |
Germany |
| Dominiak, Peter (Univ Lübeck 201201 President + Professor) |
President/Director/Head Business Group/Unit/Division |
University of Lübeck (Universität zu Lübeck, UzL) |
Germany |
| Dominici, Massimo (Univ Modena 202006 Professor + Scientific Founder of Rigenerand) |
Professor |
University of Modena |
Italy |
| Domon, Bruno (CRP-Santé 201004 Prof + Director LCP unit before ETZ Zurich Aebersold Group) |
Professor |
CRP-Santé (Public Research Center for Health Luxembourg) |
Luxembourg |
| Doms, Lutz (Askion 201303 Managing Director) |
Managing Director |
Askion (Group) |
Germany |
| Donahue, Joseph F. (Joe) (GNS Healthcare 202204– CBO before Accenture + GeneDx + Thomson Reuters + Inforsense) |
President/Director/Head Business Group/Unit/Division |
Aitia (GNS Healthcare) (Group) |
United States (USA) |
| Donato, Karen A. (MaxCyte 201006 Executive Vice President Sales and Marketing) |
Sales Manager / Marketing Manager |
MaxCyte (Group) |
United States (USA) |
| Donnert, Gerald (Abberior GmbH 201110 Managing Director) |
Managing Director |
Abberior GmbH |
Germany |
| Donoghue, John P. (Brown University 201408 Professor + Wyss Center at Campus Biotech Geneva) |
Professor |
Brown University |
United States (USA) |
| Doomernik, Chris (Health Valley Netherlands 202009 Managing Director) |
Managing Director |
Health Valley Netherlands |
Netherlands |
| Dootson, John (Cyprotex 201608 CFO) |
Chief Financial Officer (CFO) |
Evotec (Group) |
United Kingdom (GB) |
| Doppler, Clemens (3i Germany 2007 Director Healthcare Team) |
Investment Manager |
3i (Group) |
Germany |
| Doppler, Liesa (Austria (govt) 202310 Program Lead LISA) |
Cluster Manager |
Austria (govt) |
Austria |
| Dorigatti, Roberto (Evotec 201803 SVP Integrated Development Programmes) |
President/Director/Head Business Group/Unit/Division |
Evotec (Group) |
Germany |
| Dormann, Jürgen |
Chief Executive Officer (CEO) |
Sanofi (Group) [since May 2011] |
Germany |
| Dorn, Ingmar (Bayer Technology Services GmbH 200503) |
n. a. |
Bayer (Group) |
Germany |
| Dorner-Ciossek, Cornelia (Boehringer 202212 Digital Health Head) |
President/Director/Head Business Group/Unit/Division |
Boehringer Ingelheim (Group) |
Germany |
| Dornheim, Matthias (VWR International 200809) |
n. a. |
Avantor (Group) |
Germany |
| Doron, Yossi (BioTag Ltd 201302 Business Development Manager) |
Business Development Manager / Strategy Manager |
BioTag Ltd. |
Israel |
| Dorrepaal, Karin Louise (Schering 200602) |
n. a. |
Bayer (Group) |
Germany |
| Dorrestein, Pieter C. (Univ California San Diego 201201 Chemistry Faculty) |
Head Mass Spectrometry / NMR Laboratory (university / research institute) |
University of California, San Diego, Dorrestein Lab |
United States (USA) |
| Dorsch, Katharina (Gimv 2016– Associate Health & Care team in Munich= |
n. a. |
Gimv (Group) |
Germany |
| Dorsey, Brian T. (MagnaSci Ventures 201704 Founding Partner) |
Managing Partner (investment firm) |
MagnaSci Ventures |
United States (USA) |
| Dorton, Katina (AvroBio 201709– CFO before Immatics + Needham & Co + Morgan Stanley + Sullivan & Chromwell) |
Chief Financial Officer (CFO) |
AvroBio (Group) |
United States (USA) |
| Dosch, Dominik (Max Planck 201207 MPI for Biochemistry Protein Analytics) |
n. a. |
Max Planck Society for the Advancement of Science |
Germany |
| Dossetter, Alexander (MedChemica Ltd 201306 Managing Director + Founder before AstraZeneca) |
Managing Director |
MedChemica Ltd. |
United Kingdom (GB) |
| Dostatni, Ralf (Milenia Biotec GmbH 201110 Managing Director) |
Managing Director |
Milenia Biotec GmbH |
Germany |
| Doudna, Jennifer (Univ California Berkeley 201412) |
Researcher (university / research institute) |
University of California (System) |
United States (USA) |
| Dougherty, James B. (Arcus Ventures 2007– General Partner + Co-founder) |
General Partner (venture partner) |
Arcus Ventures |
United States (USA) |
| Douglas, James (Exonhit– VP 200801 Corp Developm before Epigenomics 200601–200712 before Biosite) |
Business Development Manager / Strategy Manager |
Eurobio Scientific (Group) |
France |
| Dowdeswell, Christian (Lonza 201902 Head Dosage Forms + Delivery Systesm at Lonza Pharma & Biotech) |
President/Director/Head Business Group/Unit/Division |
Lonza (Group) |
Switzerland |
| Dowe, Tanja (Debiopharm 201705 Head of Debiopharm Innovation Fund) |
Investment Manager |
Debiopharm (Group) |
Switzerland |
| Doyle, Laurie (MC Services 201707 US) |
Public Relations Manager / Investor Relations Manager |
MC Services AG |
Germany |
| Doyle, Stephen (Aslan Pharmaceuticals 202103 CBO before Boehringer Ingelheim + Sanofi) |
Chief Business Officer (CBO) |
Aslan Pharmaceuticals Ltd. (Nasdaq: ASLN) |
Singapore |
| Draetta, Francesco (Omega Funds 202010 Principal) |
Principal (venture capital) |
Omega Funds (Group) |
United States (USA) |
| Draheim, Henning (Boehringer Ingelheim 201111) |
Researcher (industry) |
Boehringer Ingelheim (Group) |
Germany |
| Drake, Richard (Medical Univ of South Carolina 201905 Professor + Director of Proteomics Center) |
Professor |
Medical University of South Carolina |
United States (USA) |
| Dranoff, Glenn (Novartis 201503– Head of new Immuno-oncology Research Group before Dana Farber) |
Researcher (industry) |
Novartis (Group) |
Switzerland |
| Drees, Ulrich (Boehringer Ingelheim 201301 Corporate SVP International Project Management) |
President/Director/Head Business Group/Unit/Division |
Boehringer Ingelheim (Group) |
Germany |
| Dreher, Christian (R-Biopharm 201907 CEO) |
Chief Executive Officer (CEO) |
R-Biopharm (Group) |
Germany |
| Dreher, Ralf (R-Biopharm 201111 CEO) |
Chief Executive Officer (CEO) |
R-Biopharm (Group) |
Germany |
| Dreiling, Thomas (Creathor Ventures 2017– PR + Communications before MSLGroup) |
Public Relations Manager / Investor Relations Manager |
Creathor Ventures (Group) |
Germany |
| Dreisewerd, Klaus (Univ Münster 201606 Professor) |
Professor |
University of Münster (Westfälische Wilhelms-Universität Münster) |
Germany |
| Dreismann, Heiner (GeneNews 200810 Interim CEO + Lead Director before Roche Molecular Diagnostic CEO) |
Chief Executive Officer (CEO) |
GeneNews Ltd. (TSX: GEN) |
Canada |
| Drejer, Kirsten (Symphogen 2000–201608 Founding CEO since 201609 Executive Director) |
Board member, executive |
Servier (Group) |
Denmark |
| Drescher, Thomas (DASGIP AG 201201 CEO) |
Chief Executive Officer (CEO) |
Eppendorf (Group) |
Germany |
| Dreusch, Andrea B. (Micromol GmbH 201110 Managing Director) |
Managing Director |
Micromol GmbH |
Germany |
| Dreusch, Andreas H.-J. (Micromol GmbH 201110 Managing Director) |
Managing Director |
Micromol GmbH |
Germany |
| Drexhage, Karl H. (Atto-Tec 1999–) |
n. a. |
Atto-Tec GmbH |
Germany |
| Drexler, Mathias (ACIB GmbH 201108 Managing Director) |
Managing Director |
ACIB GmbH – Austrian Centre of Industrial Biotechnology |
Austria |
| Dreyer, Malu (Rheinland-Pfalz 202305 Ministerpräsidentin) |
Minister |
Rheinland-Pfalz (govt region) |
Germany |
| Driesen, Guido (Lonza 201612 CEO of Capsugel) |
Chief Executive Officer (CEO) |
Lonza (Group) |
United States (USA) |
| Driess, Matthias (TU Berlin 201008 Professor Dept of Chemistry) |
Professor |
Technical University Berlin (TU Berlin) |
Germany |
| Drijver, Alex (ChemAxon 200805 CEO before ThalesNano CEO + CFO before ComGenex CFO) |
Chief Executive Officer (CEO) |
ChemAxon (Group) |
Hungary |
| Dro, Philippe (LimmaTech Biologics 202307 Board Chair before CEO + Co-Founder before GlycoVaxyn CEO) |
Chief Executive Officer (CEO) |
LimmaTech Biologics AG |
Switzerland |
| Droller, Rémi (Kurma 201305 Managing Partner at Kurma Life Sciences Partners) |
Managing Partner (investment firm) |
Eurazeo (Group) |
France |
| Dromey, James (Murdochs Children Research Institute 201404 Head of Commercialisation) |
Sales Manager / Marketing Manager |
Murdoch Childrens Research Institute (MCRI) |
Australia |
| Dropulic, Boro (Lentigen 200601 Founder + CEO) |
Chief Executive Officer (CEO) |
Opus Bio Inc. |
United States (USA) |
| Drouet, Philippe (CRISPR Therapeutics 202102– Chief Commerical Officer before Merck & Co + Hospira + Novartis) |
Chief Commercial Officer (CCO) |
CRISPR Therapeutics (Group) |
Switzerland |
| Drumm, Joshua (Valneva 202108 VP Global Investor Relations before AC Immune) |
Public Relations Manager / Investor Relations Manager |
Valneva (Group) |
France |
| du Buman, Jean-Luc (SGS 201609 Corp Developm + Communications + PR) |
Public Relations Manager / Investor Relations Manager |
SGS (Group) |
Switzerland |
| Dubilier, Nicole (Max Planck 201309– Director of MPI Bremen + Prof at Univ Bremen) |
Professor |
Max Planck Society for the Advancement of Science |
Germany |
| Dubourg, Saori (BASF 201909 Executive Board Director) |
Board member, executive |
BASF (Group) |
Germany |
| Dubro, Claudia (Brandenburg (govt) 201912 Investment Manager at Brandenburg Kapital GmbH) |
Investment Manager |
Brandenburg (govt region) |
Germany |
| Dubruel, Gauthier (UbiSim 202110 Co-Founder) |
Company Founder |
Labster (Group) |
Switzerland |
| Dubruque, Samuel (Global Bioenergies 201710– CFO joined 2013 before Suez + Total) |
Chief Financial Officer (CFO) |
Global Bioenergies (Group) |
France |
| Dubuis, Benoît (Campus Biotech Geneva 201601 Site Director) |
President/Director/Head Business Group/Unit/Division |
Campus Biotech Innovation Center (Geneva, former Merck Serono site) |
Switzerland |
| Dubuis, Olivier (Viollier 201106) |
n. a. |
Viollier AG |
Switzerland |
| Duchemin, Jeffrey A. (Harvard Bioscience 201410 CEO) |
Chief Executive Officer (CEO) |
Harvard Bioscience (Group) |
United States (USA) |
| Duchesne de Lamotte, Hervé (ExonHit 200911– CFO before Cirrus Finance Management before IDM Paris) |
Chief Financial Officer (CFO) |
Eurobio Scientific (Group) |
France |
| Duci, Barbara (Evolva 202103 Head of Investor + Corporate Relations) |
Public Relations Manager / Investor Relations Manager |
Evolva (Group) |
Switzerland |
| Duckworth, Justin (Transimmune 202209– CEO) |
Chief Executive Officer (CEO) |
Transimmune AG |
Germany |
| Ducrey, Bertrand (Debiopharm 201610 CEO of Debiopharm International) |
Chief Executive Officer (CEO) |
Debiopharm (Group) |
Switzerland |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo.svg){kind=logo}
1 2 3 ... 16 17 18 ... 86 87 88 
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
